Boothbay Fund Management, LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $7.07 Million - $10.7 Million	-75,500 Reduced 97.29%	2,100 $271,000
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $2.18 Million - $4.04 Million	-32,400 Reduced 29.45%	77,600 $7.48 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $8.77 Million - $10.6 Million	85,600 Added 350.82%	110,000 $13.3 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $10.9 Million - $16.1 Million	-102,700 Reduced 80.8%	24,400 $2.79 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $14.9 Million - $19.8 Million	127,100 New	127,100 $17.5 Million

470

79.3M

4.23M

1.21M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.8B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.